CryoLife Financials
| CYL Stock | EUR 26.65 0.10 0.37% |
CryoLife |
Understanding current and past CryoLife Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CryoLife's financial statements are interrelated, with each one affecting the others. For example, an increase in CryoLife's assets may result in an increase in income on the income statement.
CryoLife Stock Summary
CryoLife competes with Abbott Laboratories, Abbott Laboratories, Medtronic PLC, Stryker, and Boston Scientific. CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US2289031005 |
| Business Address | 1655 Roberts Boulevard |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | artivion.com |
| Phone | 770 419 3355 |
| Currency | EUR - Euro |
You should never invest in CryoLife without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CryoLife Stock, because this is throwing your money away. Analyzing the key information contained in CryoLife's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CryoLife Key Financial Ratios
There are many critical financial ratios that CryoLife's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CryoLife reports annually and quarterly.| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 | |||
| Target Price | 34.19 | |||
| Beta | 1.38 | |||
| Z Score | 0.6 |
CryoLife Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CryoLife's current stock value. Our valuation model uses many indicators to compare CryoLife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CryoLife competition to find correlations between indicators driving CryoLife's intrinsic value. More Info.CryoLife is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CryoLife's earnings, one of the primary drivers of an investment's value.CryoLife Systematic Risk
CryoLife's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CryoLife volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on CryoLife correlated with the market. If Beta is less than 0 CryoLife generally moves in the opposite direction as compared to the market. If CryoLife Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CryoLife is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CryoLife is generally in the same direction as the market. If Beta > 1 CryoLife moves generally in the same direction as, but more than the movement of the benchmark.
CryoLife December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CryoLife help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CryoLife. We use our internally-developed statistical techniques to arrive at the intrinsic value of CryoLife based on widely used predictive technical indicators. In general, we focus on analyzing CryoLife Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CryoLife's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.41 | |||
| Information Ratio | 0.1372 | |||
| Maximum Drawdown | 7.92 | |||
| Value At Risk | (2.51) | |||
| Potential Upside | 3.91 |
Complementary Tools for CryoLife Stock analysis
When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |